Study of peripheral muscle strength and severity indexes in individuals with chronic obstructive pulmonary disease

Physiotherapy Research International

Volumn 15, Issue 3, 2010, Pages 135-134

  Marino, Diego Marmorato ^a   Marrara, Kamilla Tays ^b   Ike, Daniela ^a   De Oliveira, Antônio Delfino ^c   Jamami, Maurício ^a   Di Lorenzo, Valéria Amorim Pires ^a  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b Physical Therapy Department of the University Central Paulista UNICEP   (Brazil)

^c Santa Casa de Misericórdia Hospital São Carlos   (Brazil)

Author keywords

BODE (body mass index, airflow obstruction, dyspnea, exercise performance); Body composition; Chronic obstructive pulmonary disease; Muscle strength; Physiotherapy

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE; WALKING;

AGED; AIRWAY OBSTRUCTION; BODY COMPOSITION; BODY MASS INDEX; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; WALKING;

EID: 78149391151     PISSN: 13582267     EISSN: 15206483     Source Type: Journal    
DOI: 10.1002/pri.454     Document Type: Article

References (44)

1. American Thoracic Society - European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1999; 159: 1-28.
2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 2002; 166: 111-117.
3. Borg GA. Psychophysical bases of perceived exertion. Medicine & Science in Sports & Exercise 1982; 14: 377-381.
4. Baarends EM, Schols AMWJ, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. The European Respiratory Journal 1997; 10: 2807-2813.
5. Balogum JA, Akomolafe CT, Amusa LO. Grip strength: effects of testing posture and elbow position. Archives of Physical Medicine and Rehabilitation 1991; 72: 280-283.
6. Bernard S, Leblanc P, Whitton F, Carrier G, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 1998; 158: 29-39.
7. Boadella JM, Kuijer PP, Sluiter JK, Frings-Dresen MH. Effect of self-selected handgrip position on maximal handgrip strength. Archives of Physical Medicine and Rehabilitation 2005; 86: 328-331.
8. Buchman AS, Wilson RS, Bienias JL, Bennett DA. Change in frailty and risk of death in older persons. Experimental Aging Research 2009; 35: 61-82.
9. Cardoso F, Tufanin AT, Colucci M, Nascimento O, Jardim JR. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE index applied to patients with COPD. An equivalency study. Chest 2007; 132: 477-482.
10. Casas A, Vilaro J, Rabinovich R, Mayer A, Barberà JA, Rodriguez-Roisin R, Roca J. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128: 55-61.
11. Castagna O, Boussuges A, Vallier JM, Prefaut C, Brisswalter J. Is impairment similar between arm and leg cranking exercise in COPD patients? Respiratory Medicine 2007; 101: 547-553.
12. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007; 131: 696-704.
13. Celli BR, Cote CG, Marín JM, Casanova C, Oca MM, Mendez R, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004; 350: 1005-1012.
14. Decramer M, Benedetto FD, Del Ponte A. Systemic effects of COPD. Respiratory Medicine 2005; 99: S3-S10.
15. Dourado VZ, Antunes LC, Tanni SE, De Paiva SA, Padovani CR, Godoy I. Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients. Chest 2006a; 129: 551-557.
16. Dourado VZ, Tanni SE, Vale AA, Faganello MM, Sanchez FF, Figüeiroa F, Godoy I. Manifestações sistêmicas na doença pulmonar obstrutiva crônica. Jornal Brasileiro de Pneumologia 2006b; 32: 161-171.
17. Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K. Physical performance and muscular characteristics in different stages of COPD. Scandinavian Journal of Medicine & Science in Sports 2008; 19(6): 865-870.
18. Fernandes AC, Bezerra OMP. Terapia nutricional na doença pulmonar obstrutiva crônica e suas complicações nutricionais. Jornal Brasileiro de Pneumologia 2006; 32: 461-471.
19. Figueiredo IM, Sampaio RF, Mancini MC, Silva FCM, Souza MAP. Teste de força de preensão utilizando dinamômetro Jamar. Acta Fisiatrica 2007; 14: 104-110.
20. Furlanetto KC, Cavalaro AEP, Probst VS, Brunetto AF, Pitta F. Força muscular periférica e índice BODE em pacientes com DPOC. Revista Brasileira Fisioterapia 2008; 12: 89-90.
21. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007; 176: 532-555.
22. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. American Journal of Respiratory and Critical Care Medicine 1996; 153: 976-980.
23. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. American Journal of Respiratory and Critical Care Medicine 1995; 152: 2021-2031.
24. Heijdra YF, Pinto-Plata V, Frants R, Rassulo J, Kenney L, Celli BR. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 2003; 124: 75-82.
25. Jenkins SC. 6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation. Physiotherapy 2007; 93: 175-182.
26. Kraemer WJ, Adams K, Cafarelli E. Dudley GA, Dooly C, Fleck SJ, Franklin B, Fry AC. Progression models in resistance training for healthy adults. Medicine and Science in Sports and Exercise 2002; 34: 364-380.
27. Luna-Heredia E, Martín-Peña G, Ruiz-Galiana J. Handgrip dynamometry in healthy adults. Clinical Nutrition 2005; 24: 250-258.
28. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respiratory Research 2001; 2: 216-224.
29. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest 1998; 93: 580-586.
30. Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AGN, Celli BR. Prediction of risk of COPD exacerbations by the BODE index. Respiratory Medicine 2009; 103: 373-378.
31. Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin J, Carner G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2002; 166: 809-813.
32. Moreira D, Godoy JR, Junior WS. Estudo sobre a realização da preensão palmar com a utilização do dinamômetro: considerações anatômicas e cinesiológicas. Fisioterapia Brasil 2001; 2: 295-300.
33. a ed. São Paulo: Artes Médicas, 2003.
34. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, PreFault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 2006; 173: 1390-1413.
35. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. American Journal of Respiratory and Critical Care Medicine 2003; 167: 544-549.
36. Pereira MIR, Gomes PSC. Muscular resistence and strength: reliability and prediction of maximum repetition- revision and new evidence. Revista Brasileira de Medicina do Esporte 2003; 9: 325-335.
37. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. The European Respiratory Journal 2004; 23: 28-33.
38. Pitta F, Troosters T, Spruit MA, Decramer PM, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2005; 171: 972-977.
39. Prescott E, Almdal T, Mikkelsenz KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. The European Respiratory Journal 2002; 20: 539-544.
40. Schols AM, Mastert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991; 46: 695-699.
41. Steiner MC, Barton RL, Singh SJ, Morgan MDL. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. The European Respiratory Journal 2002; 19: 626-631.
42. Vilaro J, Rabinovich R, Gonzalez-deSuso JM, Troosters T, Rodríguez D, Barberà JA, Roca J. Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. American Journal of Physical Medicine & Rehabilitation 2009; 88: 39-46.
43. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnea ratings and lung function in patients with severe COPD. The European Respiratory Journal 1994; 7: 725-729.
44. Willett W. Nutritional Epidemiology. 2nd edition. Oxford: Oxford University Press, 1998.